Rhythm Pharmaceuticals (RYTM) Cash & Equivalents (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) recorded Cash & Equivalents of $39.98 million in Q3 2026, down 24.2% from $52.75 million a year earlier and down 39.1% from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Rhythm Pharmaceuticals reported Cash & Equivalents of $54.3 million, down 39.1% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $89.14 million in FY2024 (+47.6%), $60.41 million in FY2023 (-52.8%), $128.01 million in FY2022 (+114.9%) and $59.58 million in FY2021 (-41.2%).
- The Q3 2026 figure is the lowest quarterly Cash & Equivalents since Q4 2017.
- On a year-over-year basis, Cash & Equivalents has declined for four consecutive quarters, with an average decline of 2.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 114.9% in Q4 2022, against a decline of 65.0% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $65.61 million (Q2 2026), $62.14 million (Q1 2026) and $54.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Rhythm Pharmaceuticals | 7.90 Bn | 6.52 Bn | 79.96 Mn | 39.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 39.98 Mn |
| Jun 30, 2026 | 65.61 Mn |
| Mar 31, 2026 | 62.14 Mn |
| Dec 31, 2025 | 54.30 Mn |
| Sep 30, 2025 | 52.75 Mn |
| Jun 30, 2025 | 136.11 Mn |
| Mar 31, 2025 | 106.56 Mn |
| Dec 31, 2024 | 89.14 Mn |
| Sep 30, 2024 | 47.98 Mn |
| Jun 30, 2024 | 162.13 Mn |
| Mar 31, 2024 | 53.89 Mn |
| Dec 31, 2023 | 60.41 Mn |
| Sep 30, 2023 | 64.92 Mn |
| Jun 30, 2023 | 116.01 Mn |
| Mar 31, 2023 | 109.99 Mn |
| Dec 31, 2022 | 128.01 Mn |
| Sep 30, 2022 | 185.42 Mn |
| Jun 30, 2022 | 113.54 Mn |
| Mar 31, 2022 | 78.87 Mn |
| Dec 31, 2021 | 59.58 Mn |
API Access
Rhythm Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();